Status:
COMPLETED
Determination of the GI and II Values of Soft Drink and Soft Drink With Sugardown™
Lead Sponsor:
Boston Therapeutics
Conditions:
Postprandial Hyperglycemia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study was a partly controlled laboratory-based study comparing the glycemic and insulinemic indices of 3 test meals containing soft drink alone or with SUGARDOWN™ (Galactomannan) in overweight ad...
Detailed Description
STUDY SUMMARY This study was a partly controlled, laboratory-based study comparing the short-term postprandial glucose and insulin responses produced by three test meals containing soft drink consumed...
Eligibility Criteria
Inclusion
- Aged between 18-65 years.
- Non-smoker.
- Stable body weight within the overweight weight range for their height (BMI values 25 kg/m2 for Causcasian individuals and \>23 kg/m2 for Asian individuals).
- Normal dietary habits; not dieting or eating in an overly restrictive fashion in the past 3 months.
- A regular pattern of low to moderate physical activity.
- Able to fast for ≥ 10 hours the night before each test session.
- Able to refrain from eating a legume-based evening meal or drinking alcohol the day before each test session.
- Finds the test foods suitable for consumption within 12 minutes.
- Not taking any treatment for anorexia, weight loss, or any form of treatment or medication likely to interfere with metabolism or dietary habits.
- Signed the informed consent form for the study.
Exclusion
- Currently following a restrictive diet (low-calorie, low-carbohydrate, vegan).
- Any clinically significant physical or mental illness.
- Suffering from a food allergy or serious food intolerance.
- Regularly taking prescription medication other than standard contraceptive medication.
- Females who are currently pregnant, breast-feeding, trying to become pregnant or not using an acceptable contraceptive.
- Participating in another clinical trial or participated in another clinical trial within the two weeks.
- Undergoing general anaesthesia in the month prior to inclusion.
- Subject in a situation, which in the investigator's opinion could interfere with optimal participation in the present study or could constitute a special risk for the subject.
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03374501
Start Date
November 1 2014
End Date
December 1 2014
Last Update
December 15 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.